“Opioid Overdoses and the Limited Treatment of Opioid Use Disorder Continue To Be Concerns for Medicare Beneficiaries,” (OEI-02-22-00390, September 2022, .pdf format, 23p.).
September 16, 2022
CAAR – US Department of Health and Human Services, Office of Inspector General Report – September 16, 2022
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – September 16, 2022
March 28, 2022
CAAR – Agency for Healthcare Research and Quality Statistical Brief – March 28, 2022
“Any Use and “Frequent Use” of Opioids among Elderly Adults in 2018-2019, by Socioeconomic Characteristics,” by Asako S. Moriya and Zhengyi Fang (Statistical Brief 541, March 2022, .pdf and HTML format, 15p.).
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1286
Comments Off on CAAR – Agency for Healthcare Research and Quality Statistical Brief – March 28, 2022
March 25, 2022
CAAR – US Government Accountability Office Report – March 25, 2022
“Older Workers: Opioid Misuse and Employment Outcomes,” (GAO-22-104491, March 2022, .pdf format, 38p.).
Comments Off on CAAR – US Government Accountability Office Report – March 25, 2022
February 21, 2022
CAAR – Center for Retirement Research at Boston College Working Paper – February 21, 2022
“Employment Outcomes for Social Security Disability Insurance Applicants Who Use Opioids,” by April Yanyuan Wu, Denise Hoffman, Paul O’Leary and Dara Lee Luca (WP No. 2022-1, February 2022, .pdf format, 38p.). Note: A link to the abstract and the full-text of this paper is available at:
Comments Off on CAAR – Center for Retirement Research at Boston College Working Paper – February 21, 2022
December 16, 2021
CAAR – US Department of Health and Human Services, Office of the Inspector General Report – December 16, 2021
“Many Medicare Beneficiaries Are Not Receiving Medication to Treat Their Opioid Use Disorder,” ( OEI-02-20-00390, December 2021, .pdf format, 38p.).
Comments Off on CAAR – US Department of Health and Human Services, Office of the Inspector General Report – December 16, 2021
April 5, 2021
CAAR – Center for Retirement Research at Boston College Working Paper – April 5, 2021
“Trends in Opioid Use among Social Security Disability Insurance Applicants,” by April Yanyuan Wu, Denise Hoffman and Paul O’Leary (WP No. 2021-6, March 2021, .pdf format, 19p.). Note: A link to the abstract and the full-text of this paper is available at:
Comments Off on CAAR – Center for Retirement Research at Boston College Working Paper – April 5, 2021
February 4, 2021
CAAR – US Department of Health and Human Services, Office of the Inspector General Report – February 4, 2021
“Opioid Use in Medicare Part D During the Onset of the COVID-19 Pandemic,” (OEI-02-20-00400, February 2021, .pdf format, 10p.).
Comments Off on CAAR – US Department of Health and Human Services, Office of the Inspector General Report – February 4, 2021
October 12, 2020
CAAR – US Department of Health and Human Services, Office of the Inspector General Report – October 12, 2020
“Update on Oversight of Opioid Prescribing and Monitoring of Opioid Use: States Have Taken Action To Address the Opioid Epidemic,” (A-09-20-01000, October 2020, .pdf format, 33p.).
Comments Off on CAAR – US Department of Health and Human Services, Office of the Inspector General Report – October 12, 2020
August 18, 2020
CAAR – Journal of the American Medical Association Research Letter Abstract – August 18, 2020
“Prevalence of Psychotropic and Opioid Prescription Fills Among Community-Dwelling Older Adults With Dementia in the US,” by Donovan T. Maust, Julie Strominger, Julie P. W. Bynum, Kenneth M. Langa, Lauren B. Gerlach, Kara Zivin, and Steven C. Marcus (Vol. 324, No. 7, August 18, 2020, p. 706-708).
Comments Off on CAAR – Journal of the American Medical Association Research Letter Abstract – August 18, 2020
May 13, 2020
CAAR – US Department of Health and Human Service, Office of Inspector General Report – May 13, 2020
“Medicare Part D Beneficiaries at Serious Risk of Opioid Misuse or Overdose: A Closer Look,” (OEI-02-19-00130, May 2020, .pdf format, 24p.).
Comments Off on CAAR – US Department of Health and Human Service, Office of Inspector General Report – May 13, 2020
January 9, 2020
CAAR – US Government Accountability Office Report – January 9, 2020
“Social Security Disability: Action Needed to Help Agency Staff Understand and Follow Policies Related to Prescription Opioid Misuse,” (GAO-20-120, January 2020, .pdf format, 58p.).
Comments Off on CAAR – US Government Accountability Office Report – January 9, 2020
November 27, 2019
CAAR – Medical Expenditure Panel Survey Report – November 27, 2019
“Average Annual Morphine Milligram Equivalents (MMEs) of Outpatient Prescription Opioids and Share of Total MMEs among Elderly and Non-Elderly Adults in 2015-2016,” by Asako S. Moriya and G. Edward Miller (Research Findings 45, November 2019, .pdf and HTML format, 25p.).
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Research+Findings&opt=2&id=1263
Comments Off on CAAR – Medical Expenditure Panel Survey Report – November 27, 2019
May 20, 2019
CAAR – US Government Accountability Office Report – May 20, 2019
“Prescription Opioids: Voluntary Medicare Drug Management Programs to Control Misuse,” (GAO-19-446, May 2019, .pdf format, 21p.).
Comments Off on CAAR – US Government Accountability Office Report – May 20, 2019
April 18, 2019
CAAR – US Department of Health and Human Services, Office of Inspector General Report – April 18, 2019
“Concerns About Opioid Use in Medicare Part D in the Appalachian Region,” (OEI-02-18-00224, April 2019, .pdf format, 13p.).
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – April 18, 2019
December 10, 2018
CAAR – National Bureau of Economic Research Working Papers – December 10, 2018
Links to an abstract are available. For full text availability check your organization’s library.
A. “Annuity Pricing in Public Pension Plans: Importance of Interest Rates,” by Nino Abashidze, Robert L. Clark, Beth Ritter, and David Vanderweide (w25343, December 2018, .pdf format, 37p.).
B. “The Effects of Medicare Advantage on Opioid Use,” by Laurence C. Baker, Kate Bundorf, and Daniel Kessler (w25327, December 2018, .pdf format, 28p.).
C. “The Long-run Impact of New Medical Ideas on Cancer Survival and Mortality,” by Frank R. Lichtenberg (w25328, December 2018, .pdf format, 19p.).
D. “Two Hundred Years of Health and Medical Care: The Importance of Medical Care for Life Expectancy Gains,” by Maryaline Catillon, David Cutler, and Thomas Getzen (w25330, December 2018, .pdf format, 56p.).
E. “The Effect of Economic Conditions on the Disability Insurance Program: Evidence from the Great Recession,” by Nicole Maestas, Kathleen J. Mullen, and Alexander Strand (w25338, December 2018, .pdf format, 33p.).
Comments Off on CAAR – National Bureau of Economic Research Working Papers – December 10, 2018
September 20, 2018
CAAR – Medical Expenditure Panel Survey Statistical Brief – September 20, 2018
“Any Use and Frequent Use of Opioids among Elderly Adults in 2015-2016, by Socioeconomic Characteristics,” by Asako S. Moriya and G. Edward Miller (Statistical Brief 515, September 2018, .pdf and HTML format, 7p.).
meps.ahrq.gov/mepsweb/data_stats/Pub_ProdResults_Details.jsp?pt=Statistical+Brief&opt=2&id=1237
Comments Off on CAAR – Medical Expenditure Panel Survey Statistical Brief – September 20, 2018
June 29, 2018
CAAR – US Department of Health and Human Services, Office of Inspector General Report – June 29, 2018
“Opioid Use in Medicare Part D Remains Concerning,” (OEI-02-18-00220, June 2018, .pdf format, 23p.).
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Report – June 29, 2018
May 30, 2018
CAAR – US Senate Committe on Finance, Subcommittee on Health Hearing Testimony – May 30, 2018
“Examining Efforts to Prevent Opioid Overutilization and Misuse in Medicare and Medicaid,” a hearing held May 29, 2018 (witness statements available in .pdf format, video of the full hearing available at the site, running time hour minutes).
Comments Off on CAAR – US Senate Committe on Finance, Subcommittee on Health Hearing Testimony – May 30, 2018
May 24, 2018
CAAR – US Senate Special Committee on Aging Hearing Testimony – May 24, 2018
“Preventing and Treating Opioid Misuse Among Older Americans,” a hearing held May 23, 2018 (witness statements available in .pdf format, video of the full hearing available at the site, running time 1 hour 20 minutes). Note: The hearing begins at the 14:06 mark.
www.aging.senate.gov/hearings/preventing-and-treating-opioid-misuse-among-older-americans
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – May 24, 2018
April 23, 2018
CAAR – US Senate Committee on Finance Hearing Testimony – April 23, 2018
“Tackling Opioid and Substance Use Disorders in Medicare, Medicaid, and Human Services Programs,” a hearing held April 19, 2018 (witness statements available in .pdf format, video of the full hearing available at the site, running time hour minutes).
Comments Off on CAAR – US Senate Committee on Finance Hearing Testimony – April 23, 2018
March 6, 2018
CAAR – Journal of the American Medical Association Article Abstracts – March 6, 2018
A. “Effect of Opioid vs Nonopioid Medications on Pain-Related Function in Patients With Chronic Back Pain or Hip or Knee Osteoarthritis Pain: The SPACE Randomized Clinical Trial,” by Erin E. Krebs, Amy Gravely, Sean Nugent, Agnes C. Jensen, Beth DeRonne, Elizabeth S. Goldsmith, Kurt Kroenke, Matthew J. Bair, and Siamak Noorbaloochi (Vol. 319, No. 9, March 6, 2018, p. 872-882).
jamanetwork.com/journals/jama/article-abstract/2673971
B. “Effect of a Low-Intensity PSA-Based Screening Intervention on Prostate Cancer Mortality: The CAP Randomized Clinical Trial,” by Richard M. Martin, Jenny L. Donovan, Emma L. Turner, Chris Metcalfe, Grace J. Young, Eleanor I. Walsh, J. Athene Lane, Sian Noble, Steven E. Oliver, Simon Evans, Jonathan A. C. Sterne, Peter Holding, Yoav Ben-Shlomo, Peter Brindle, Naomi J. Williams, Elizabeth M. Hill, Siaw Yein Ng, Jessica Toole, Marta K. Tazewell, Laura J. Hughes, Charlotte F. Davies, Joanna C. Thorn, Elizabeth Down, George Davey Smith, David E. Neal, and Freddie C. Hamdy, for the CAP Trial Group (Vol. 319, No. 9, March 6, 2018, p. 883-895).
Comments Off on CAAR – Journal of the American Medical Association Article Abstracts – March 6, 2018
February 8, 2018
CAAR – US House Committee on Ways and Means, Subcommittee on Health Hearing Testimony – February 8, 2018
“Hearing on the Opioid Crisis: Removing Barriers to Prevent and Treat Opioid Abuse and Dependence in Medicare,” a hearing held February 6, 2018 (witness statements available in .pdf format, video of the full hearing available at the site). Note: Hearing begins at the 8:37 and goes to the 1:23 mark (Panel 1). The second half of the hearing begins at the 2:26:27 mark and ends at the 3:32:50 mark.
Comments Off on CAAR – US House Committee on Ways and Means, Subcommittee on Health Hearing Testimony – February 8, 2018
January 17, 2018
CAAR – US House Committee on Ways and Means, Subcommittee on Oversight Hearing Testimony – January 17, 2018
“The Opioid Crisis: The Current Landscape and CMS Actions to Prevent Opioid Misuse,” a hearing held January 17, 2018 (witness statements available in .pdf format).
Comments Off on CAAR – US House Committee on Ways and Means, Subcommittee on Oversight Hearing Testimony – January 17, 2018
November 6, 2017
CAAR – US Government Accountability Office Report – November 6, 2017
“Prescription Opioids: Medicare Needs to Expand Oversight Efforts to Reduce the Risk of Harm,” (GAO-18-15, October 2017, .pdf format, 35p.).
Comments Off on CAAR – US Government Accountability Office Report – November 6, 2017
September 5, 2017
CAAR – Grantmakers in Aging Report – September 5, 2017
“Heartache, Pain, and Hope: Rural Communities, Older People, and the Opioid Crisis: An Introduction for Funders,” (August 2017, .pdf format, 21p.).
www.giaging.org/documents/170823_GIA_Rural_Opioid_Paper_FINAL_for_web.pdf
Comments Off on CAAR – Grantmakers in Aging Report – September 5, 2017
July 13, 2017
CAAR – US Department of Health and Human Services Brief – July 13, 2017
“Opioids in Medicare Part D: Concerns about Extreme Use and Questionable Prescribing,” (OEI-02-17-00250, July 2017, .pdf format, 16p.).
Comments Off on CAAR – US Department of Health and Human Services Brief – July 13, 2017
April 5, 2017
CAAR – US Senate Special Committee on Aging Hearing Testimony – April 5, 2017
“Grandparents to the Rescue: Raising Grandchildren in the Opioid Crisis and Beyond,” a hearing held March 21, 2017 (witness statement available in .pdf format, video of the full hearing available at the site, running time 1 hour 39 minutes). Note: Hearing begins at the 14:32 mark.
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – April 5, 2017
February 13, 2017
CAAR – National Bureau of Economic Research Working Paper – February 13, 2017
Links to an abstract are available. For full text availability check your organization’s library.
A. “Did Medicaid Expansion Reduce Medical Divorce?” by David Slusky and Donna Ginther (w23139, February 2017, .pdf format, 8p.).
B. “The Effect of Prescription Drug Monitoring Programs on Opioid Utilization in Medicare,” by Thomas C. Buchmueller and Colleen Carey (w23148, February 2017, .pdf format, p.).
Comments Off on CAAR – National Bureau of Economic Research Working Paper – February 13, 2017
October 17, 2016
CAAR – Rand Corporation Labor and Population Center Working Paper – October 17, 2016
“How Increasing Medical Access to Opioids Contributes to the Opioid Epidemic: Evidence from Medicare Part D,” by David Powell, Rosalie Liccardo Pacula, and Erin Audrey Taylor (WR-1169, September 2016, .pdf format, 52p.). Note: Links to the abstract and the full text of the paper available at:
Comments Off on CAAR – Rand Corporation Labor and Population Center Working Paper – October 17, 2016
June 23, 2016
CAAR – US Department of Health and Human Services, Office of Inspector General Brief – June 23, 2016
“High Part D Spending on Opioids and Substantial Growth in Compounded Drugs Raise Concerns,” (OEI-02-16-00290, June 2016, .pdf format, 13p.).
Comments Off on CAAR – US Department of Health and Human Services, Office of Inspector General Brief – June 23, 2016
February 24, 2016
CAAR – US Senate Special Committee on Aging Hearing Testimony – February 24, 2016
“Opioid Use Among Seniors – Issues and Emerging Trends,” a hearing held February 24, 2016 (witness statement available in .pdf format, video of the full hearing available at the site, running time 1 hour 47 minutes). Note: Hearing begins at the 13:54 mark.
www.aging.senate.gov/hearings/opioid-use-among-seniors_issues-and-emerging-trends
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – February 24, 2016
February 3, 2016
CAAR – US Senate Special Committee on Aging Hearing Testimony – February 3, 2016
“Fighting Against a Growing Epidemic: Opioid Misuse and Abuse Among Older Americans,” a hearing held February 1, 2016 (witness statements available in .pdf format).
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – February 3, 2016
January 19, 2016
CAAR – US Senate Special Committee on Aging Hearing Testimony – January 19, 2016
“Fighting Against a Growing Epidemic: Reducing the Misuse and Abuse of Opioids in America,” a hearing held January 19, 2016 (witness statements available in .pdf format).
Comments Off on CAAR – US Senate Special Committee on Aging Hearing Testimony – January 19, 2016
April 7, 2015
CAAR – National Bureau of Economic Research Working Paper – April 7, 2015
Links to an abstract are available. For full text availability check your organization’s library. “Does Prescription Drug Coverage Increase Opioid Abuse? Evidence from Medicare Part D,” by Rosalie Liccardo Pacula, David Powell, and Erin Taylor (w21072, April 2015, .pdf format, 43p.).
Comments Off on CAAR – National Bureau of Economic Research Working Paper – April 7, 2015
February 28, 2014
CAAR – British Medical Journal Articles – February 28, 2014
A. “Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims,” by Anupam B. Jena, Dana Goldman, Leonard D. Schaeffer, Lesley Weaver, and Pinar Karaca-Mandic (Vol. 348, No. 7947, March 1, 2014, BMJ 2014;348:g1393, .pdf and HTML format).
www.bmj.com/content/348/bmj.g1393
B. “Comparative effectiveness of radical prostatectomy and radiotherapy in prostate cancer: observational study of mortality outcomes,” by Prasanna Sooriakumaran, Tommy Nyberg, Olof Akre, Leif Haendler, Inge Heus, Mats Olsson, Stefan Carlsson, Monique J. Roobol, Gunnar Steineck, and Peter Wiklund (Vol. 348, No. 7947, March 1, 2014, BMJ 2014;348:g1502, .pdf and HTML format).
Comments Off on CAAR – British Medical Journal Articles – February 28, 2014
